Antibiotic resistance and consumption before and during the COVID-19 pandemic in Valle del Cauca, Colombia.

Objective: To assess changes in antibiotic resistance of eight of the World Health Organization priority bug-drug combinations and consumption of six antibiotics (ceftriaxone, cefepime, piperacillin/tazobactam, meropenem, ciprofloxacin, vancomycin) before (March 2018 to July 2019) and during (March 2020 to July 2021) the COVID-19 pandemic in 31 hospitals in Valle del Cauca, Colombia. Methods: This was a before/after study using routinely collected data. For antibiotic consumption, daily defined doses (DDD) per 100 bed-days were compared. Results: There were 23 405 priority bacterial isolates with data on antibiotic resistance. The total number of isolates increased from 9 774 to 13 631 in the periods before and during the pandemic, respectively. While resistance significantly decreased for four selected bug-drug combinations (Klebsiella pneumoniae, extended spectrum beta lactamase [ESBL]-producing, 32% to 24%; K. pneumoniae, carbapenem-resistant, 4% to 2%; Pseudomonas aeruginosa, carbapenem-resistant, 12% to 8%; Acinetobacter baumannii, carbapenem-resistant, 23% to 9%), the level of resistance for Enterococcus faecium to vancomycin significantly increased (42% to 57%). There was no change in resistance for the remaining three combinations (Staphylococcus aureus, methicillin-resistant; Escherichia coli, ESBL-producing; E. coli, carbapenem-resistant). Consumption of all antibiotics increased. However, meropenem consumption decreased in intensive care unit settings (8.2 to 7.1 DDD per 100 bed-days). Conclusions: While the consumption of antibiotics increased, a decrease in antibiotic resistance of four bug-drug combinations was observed during the pandemic. This was possibly due to an increase in community-acquired infections. Increasing resistance of E. faecium to vancomycin must be monitored. The findings of this study are essential to inform stewardship programs in hospital settings of Colombia and similar contexts elsewhere.

Antibiotic resistance and consumption before and during the COVID-19 pandemic in Valle del Cauca, Colombia

[ABSTRACT]. Objective. To assess changes in antibiotic resistance of eight of the World Health Organization priority bug-drug combinations and consumption of six antibiotics (ceftriaxone, cefepime, piperacillin/tazobactam, meropenem, ciprofloxacin, vancomycin) before (March 2018 to July 2019) and during (March 2020 to July 2021) the COVID-19 pandemic in 31 hospitals in Valle del Cauca, Colombia. Methods. This was a before/after study using routinely collected data. For antibiotic consumption, daily defined doses (DDD) per 100 bed-days were compared. Results. There were 23 405 priority bacterial isolates with data on antibiotic resistance. The total number of isolates increased from 9 774 to 13 631 in the periods before and during the pandemic, respectively. While resistance significantly decreased for four selected bug-drug combinations (Klebsiella pneumoniae, extended spectrum beta lactamase [ESBL]-producing, 32% to 24%; K. pneumoniae, carbapenem-resistant, 4% to 2%; Pseudomonas aeruginosa, carbapenem-resistant, 12% to 8%; Acinetobacter baumannii, carbapenem-resis- tant, 23% to 9%), the level of resistance for Enterococcus faecium to vancomycin significantly increased (42% to 57%). There was no change in resistance for the remaining three combinations (Staphylococcus aureus, methicillin-resistant; Escherichia coli, ESBL-producing; E. coli, carbapenem-resistant). Consumption of all anti- biotics increased. However, meropenem consumption decreased in intensive care unit settings (8.2 to 7.1 DDD per 100 bed-days). Conclusions. While the consumption of antibiotics increased, a decrease in antibiotic resistance of four bug-drug combinations was observed during the pandemic. This was possibly due to an increase in commu- nity-acquired infections. Increasing resistance of E. faecium to vancomycin must be monitored. The findings of this study are essential to inform stewardship programs in hospital settings of Colombia and similar contexts elsewhere.

[RESUMEN]. Objetivo. Evaluar los cambios en la resistencia a los antibióticos de ocho de las combinaciones de fármacos y agentes patógenos incluidos en la lista prioritaria de la Organización Mundial de la Salud y el consumo de seis antibióticos (ceftriaxona, cefepima, piperacilina/tazobactam, meropenem, ciprofloxacina, vancomicina) antes de la pandemia de COVID-19 (de marzo del 2018 a julio del 2019) y durante la pandemia (de marzo del 2020 a julio del 2021) en 31 hospitales del Valle del Cauca (Colombia). Métodos. En este estudio se analiza el antes y el después empleando datos recopilados de forma rutinaria. Para el consumo de antibióticos, se compararon las dosis diarias definidas (DDD) por 100 días-cama. Resultados. Hubo 23 405 cepas bacterianas aisladas prioritarias con datos sobre la resistencia a los antibióti- cos. El número total de cepas aisladas aumentó de 9 774 antes de la pandemia a 13 631 durante la pandemia. Si bien la resistencia disminuyó significativamente en las cuatro combinaciones seleccionadas de agentes patógenos y fármacos (Klebsiella pneumoniae, productora de betalactamasa de espectro extendido [BLEE], de 32% a 24%; K. pneumoniae, resistente a los carbapenémicos, de 4% a 2%; Pseudomonas aeruginosa, resistente a los carbapenémicos, de 12% a 8%; Acinetobacter baumannii, resistente a los carbapenémicos, de 23% a 9%), el nivel de resistencia de Enterococcus faecium a la vancomicina aumentó significativamente (de 42% a 57%). No hubo cambios en la resistencia en las tres combinaciones restantes (Staphylococcus aureus, resistente a la meticilina; Escherichia coli, productora de BLEE; E. coli, resistente a los carbapenémi- cos). El consumo de todos los antibióticos aumentó. Sin embargo, el consumo de meropenem disminuyó en los entornos de las unidades de cuidados intensivos (de 8,2 a 7,1 DDD por 100 días-cama). Conclusiones. Aunque el consumo de antibióticos aumentó, se observó una disminución en la resistencia a los antibióticos de cuatro combinaciones de agentes patógenos y medicamentos durante la pandemia, que posiblemente se debió a un aumento en las infecciones adquiridas en la comunidad. Es necesario vigilar el aumento de la resistencia de E. faecium a la vancomicina. Los resultados de este estudio son esenciales para que sirvan de orientación en los programas de optimización del uso de los antibióticos en los entornos hospitalarios de Colombia y en contextos similares en otros lugares.

[RESUMO]. Objetivo. Avaliar as mudanças na resistência a antibióticos em oito das combinações microrganismo/anti- microbiano prioritárias da Organização Mundial da Saúde e o consumo de seis antibióticos (ceftriaxona, cefepima, piperacilina/tazobactam, meropeném, ciprofloxacino, vancomicina) antes (março de 2018 a julho de 2019) e durante (março de 2020 a julho de 2021) a pandemia de COVID-19 em 31 hospitais em Valle del Cauca, Colômbia. Métodos. Este foi um estudo antes/depois utilizando dados coletados rotineiramente. Para avaliar o consumo de antibióticos, foram comparadas doses diárias definidas (DDD) por 100 leitos-dias. Resultados. Havia dados sobre resistência a antibióticos para 23.405 isolados bacterianos prioritários. O número total de isolados aumentou de 9.774 para 13.631 antes e durante a pandemia, respectivamente. Embora a resistência tenha diminuído significativamente para quatro das combinações microrganismo/antimi- crobiano selecionadas (Klebsiella pneumoniae, produtora de betalactamase de espectro estendido [ESBL], 32% a 24%; K. pneumoniae, resistente a carbapenêmicos, 4% a 2%; Pseudomonas aeruginosa, resistente a carbapenêmicos, 12% a 8%; Acinetobacter baumannii, resistente a carbapenêmicos, 23% a 9%), o nível de resistência de Enterococcus faecium a vancomicina aumentou significativamente (42% a 57%). Não houve mudança na resistência para as três combinações restantes (Staphylococcus aureus, resistente a meticilina; Escherichia coli, produtora de ESBL; E. coli, resistente a carbapenêmicos). O consumo de todos os antibióti- cos aumentou. Entretanto, o consumo de meropeném nas unidades de terapia intensiva diminuiu (de 8,2 para 7,1 DDD por 100 leitos-dias). Conclusões. Embora o consumo de antibióticos tenha aumentado, observou-se uma diminuição na resistên- cia a antibióticos de quatro combinações microrganismo/antimicrobiano durante a pandemia. Isso ocorreu possivelmente devido a um aumento nas infecções adquiridas na comunidade. O aumento da resistência de E. faecium à vancomicina deve ser monitorado. Os achados deste estudo são essenciais para guiar os pro- gramas de gerenciamento de antimicrobianos em ambientes hospitalares da Colômbia e em outros contextos similares.

Antibiotic resistance and consumption before and during the COVID-19 pandemic in Valle del Cauca, Colombia / Resistencia antibiótica y consumo de antibióticos antes y durante la pandemia de COVID-19 en el Valle del Cauca, Colombia / Resistência a antibióticos e consumo de antibióticos antes e durante a pandemia de COVID-19 no Valle del Cauca, Colômbia

ABSTRACT Objective. To assess changes in antibiotic resistance of eight of the World Health Organization priority bug-drug combinations and consumption of six antibiotics (ceftriaxone, cefepime, piperacillin/tazobactam, meropenem, ciprofloxacin, vancomycin) before (March 2018 to July 2019) and during (March 2020 to July 2021) the COVID-19 pandemic in 31 hospitals in Valle del Cauca, Colombia. Methods. This was a before/after study using routinely collected data. For antibiotic consumption, daily defined doses (DDD) per 100 bed-days were compared. Results. There were 23 405 priority bacterial isolates with data on antibiotic resistance. The total number of isolates increased from 9 774 to 13 631 in the periods before and during the pandemic, respectively. While resistance significantly decreased for four selected bug-drug combinations (Klebsiella pneumoniae, extended spectrum beta lactamase [ESBL]-producing, 32% to 24%; K. pneumoniae, carbapenem-resistant, 4% to 2%; Pseudomonas aeruginosa, carbapenem-resistant, 12% to 8%; Acinetobacter baumannii, carbapenem-resistant, 23% to 9%), the level of resistance for Enterococcus faecium to vancomycin significantly increased (42% to 57%). There was no change in resistance for the remaining three combinations (Staphylococcus aureus, methicillin-resistant; Escherichia coli, ESBL-producing; E. coli, carbapenem-resistant). Consumption of all antibiotics increased. However, meropenem consumption decreased in intensive care unit settings (8.2 to 7.1 DDD per 100 bed-days). Conclusions. While the consumption of antibiotics increased, a decrease in antibiotic resistance of four bug-drug combinations was observed during the pandemic. This was possibly due to an increase in community-acquired infections. Increasing resistance of E. faecium to vancomycin must be monitored. The findings of this study are essential to inform stewardship programs in hospital settings of Colombia and similar contexts elsewhere.

RESUMEN Objetivo. Evaluar los cambios en la resistencia a los antibióticos de ocho de las combinaciones de fármacos y agentes patógenos incluidos en la lista prioritaria de la Organización Mundial de la Salud y el consumo de seis antibióticos (ceftriaxona, cefepima, piperacilina/tazobactam, meropenem, ciprofloxacina, vancomicina) antes de la pandemia de COVID-19 (de marzo del 2018 a julio del 2019) y durante la pandemia (de marzo del 2020 a julio del 2021) en 31 hospitales del Valle del Cauca (Colombia). Métodos. En este estudio se analiza el antes y el después empleando datos recopilados de forma rutinaria. Para el consumo de antibióticos, se compararon las dosis diarias definidas (DDD) por 100 días-cama. Resultados. Hubo 23 405 cepas bacterianas aisladas prioritarias con datos sobre la resistencia a los antibióticos. El número total de cepas aisladas aumentó de 9 774 antes de la pandemia a 13 631 durante la pandemia. Si bien la resistencia disminuyó significativamente en las cuatro combinaciones seleccionadas de agentes patógenos y fármacos (Klebsiella pneumoniae, productora de betalactamasa de espectro extendido [BLEE], de 32% a 24%; K. pneumoniae, resistente a los carbapenémicos, de 4% a 2%; Pseudomonas aeruginosa, resistente a los carbapenémicos, de 12% a 8%; Acinetobacter baumannii, resistente a los carbapenémicos, de 23% a 9%), el nivel de resistencia de Enterococcus faecium a la vancomicina aumentó significativamente (de 42% a 57%). No hubo cambios en la resistencia en las tres combinaciones restantes (Staphylococcus aureus, resistente a la meticilina; Escherichia coli, productora de BLEE; E. coli, resistente a los carbapenémicos). El consumo de todos los antibióticos aumentó. Sin embargo, el consumo de meropenem disminuyó en los entornos de las unidades de cuidados intensivos (de 8,2 a 7,1 DDD por 100 días-cama). Conclusiones. Aunque el consumo de antibióticos aumentó, se observó una disminución en la resistencia a los antibióticos de cuatro combinaciones de agentes patógenos y medicamentos durante la pandemia, que posiblemente se debió a un aumento en las infecciones adquiridas en la comunidad. Es necesario vigilar el aumento de la resistencia de E. faecium a la vancomicina. Los resultados de este estudio son esenciales para que sirvan de orientación en los programas de optimización del uso de los antibióticos en los entornos hospitalarios de Colombia y en contextos similares en otros lugares.

RESUMO Objetivo. Avaliar as mudanças na resistência a antibióticos em oito das combinações microrganismo/antimicrobiano prioritárias da Organização Mundial da Saúde e o consumo de seis antibióticos (ceftriaxona, cefepima, piperacilina/tazobactam, meropeném, ciprofloxacino, vancomicina) antes (março de 2018 a julho de 2019) e durante (março de 2020 a julho de 2021) a pandemia de COVID-19 em 31 hospitais em Valle del Cauca, Colômbia. Métodos. Este foi um estudo antes/depois utilizando dados coletados rotineiramente. Para avaliar o consumo de antibióticos, foram comparadas doses diárias definidas (DDD) por 100 leitos-dias. Resultados. Havia dados sobre resistência a antibióticos para 23.405 isolados bacterianos prioritários. O número total de isolados aumentou de 9.774 para 13.631 antes e durante a pandemia, respectivamente. Embora a resistência tenha diminuído significativamente para quatro das combinações microrganismo/antimicrobiano selecionadas (Klebsiella pneumoniae, produtora de betalactamase de espectro estendido [ESBL], 32% a 24%; K. pneumoniae, resistente a carbapenêmicos, 4% a 2%; Pseudomonas aeruginosa, resistente a carbapenêmicos, 12% a 8%; Acinetobacter baumannii, resistente a carbapenêmicos, 23% a 9%), o nível de resistência de Enterococcus faecium a vancomicina aumentou significativamente (42% a 57%). Não houve mudança na resistência para as três combinações restantes (Staphylococcus aureus, resistente a meticilina; Escherichia coli, produtora de ESBL; E. coli, resistente a carbapenêmicos). O consumo de todos os antibióticos aumentou. Entretanto, o consumo de meropeném nas unidades de terapia intensiva diminuiu (de 8,2 para 7,1 DDD por 100 leitos-dias). Conclusões. Embora o consumo de antibióticos tenha aumentado, observou-se uma diminuição na resistência a antibióticos de quatro combinações microrganismo/antimicrobiano durante a pandemia. Isso ocorreu possivelmente devido a um aumento nas infecções adquiridas na comunidade. O aumento da resistência de E. faecium à vancomicina deve ser monitorado. Os achados deste estudo são essenciais para guiar os programas de gerenciamento de antimicrobianos em ambientes hospitalares da Colômbia e em outros contextos similares.

Factores asociados a la desnutrición aguda en el departamentodel Valle del Cauca entre los años 2016 y 2019 / Factors associated with acute malnutrition in the department of Valle del Cauca between 2016 and 2019

Introducción: Los primeros años de la vida son dinámicos en comparación con todo el proceso de crecimiento, el cual se caracteriza por su vulnerabilidad ante las condiciones sociales, económicas y ambientales, lo que hace necesario un estado nutricional adecuado. Objetivo: analizar los factores asociados a la desnutrición aguda en niños menores de cinco años en el Valle del Cauca entre 2016 y 2019. Metodología: se realizó un estudio descriptivo de corte transversal con análisis correlacional a la luz de los determinantes sociales en salud. La población estuvo conformada por 2.237 niños/as registrados en la base de datos básicos y complementarios de la ficha epidemiológica del evento 113 del Sistema de Vigilancia en Salud Pública. Se concluyó que los más afectados por desnutrición fueron los niños de sexo masculino con un 55,4% y en edades entre los seis y 12 meses (62%). Resultados: entre la información relativa al peso, el 78,6% tuvo un normopeso al nacer, el 88% estaban inscritos en el programa Crecimiento y Desarrollo y la mayoría tenían residencia en el área de la cabecera municipal. Las madres o cuidadores que alcanzaban un grado de escolaridad de secundaria eran un 56,73%. Conclusiones: En esa medida, en el Valle del Cauca la presencia de desnutrición aguda se relaciona con el tiempo de lactancia materna, la inscripción al programa de Crecimiento y Desarrollo, la edad del menor, la pertenencia étnica, el régimen de salud, el nivel educativo de la madre y el área de residencia.(AU)

The first years of life are dynamic compared to the entiregrowth process, which is characterized by its vulnerability tosocial, economic and environmental conditions, which makesit necessary to have an adequate nutritional status. The ob-jective of the present research consisted of analyzing the fac-tors associated with acute malnutrition in children under fiveyears of age in Valle del Cauca between 2016 and 2019. A de-scriptive cross-sectional study was conducted with correla-tional analysis in light of the social determinants of health.The population consisted of 2,237 children registered in thebasic and complementary database of the epidemiologicalrecord of event 113 of the Public Health Surveillance. The in-formation related to weight, 78,6% had normal weight atbirth, 88% were enrolled in the Growth and DevelopmentProgram and most of them lived in the area of the municipal capital. The mothers or caregivers had 56,73% secondaryschooling. Thus, in Valle del Cauca, the presence of acutemalnutrition is related to the length of breastfeeding, enroll-ment in the Growth and Development Program, age of thechild, ethnicity, health regime, educational level of the motherand area of residence. It was concluded that the most af-fected by malnutrition were males (55.4%) and aged be-tween six and 12 months (62%).(AU)

Reinfection by SARS CoV2 in Valle Del Cauca, Colombia: A Descriptive Retrospective Study.

Introduction: In coronavirus cases, reinfection has been associated with short-term immunity and genetic changes in viruses which allow them to escape from immune response, viral genotyping is required to make the precise diagnosis of reinfection, but the suspicion occurs in patients with more than 90 days between the tests and total improvement between them. We made a descriptive retrospective study with the cases of reinfection in Valle del Cauca, Colombia. Results: We found up to June 30, 3249 cases with suspected reinfection, 1.1% of all cases. During the first infection episode, 68% of the patients had symptoms, while at the moment of reinfection, the percentage was 73.4%. 55% of the analyzed cases had symptoms in both infection episodes, hospitalization of reinfection cases was 2% during the first episode and 2.2% in the second one. Conclusion: the reinfection percentage was low, as well as the hospitalization and ICU cases. These results allow to define that in terms of the provision of healthcare services, reinfection defined in this study, does not generate any differences in care required vs the first episode.

Risks of Adverse Childhood Outcomes According to Prenatal Time of Exposure to Zika Virus: Assessment in a Cohort Exposed to Zika During an Outbreak in Colombia.

Late gestational exposure to Zika increases the odds of delay in the Bayley-II mental developmental index (MDI) in children with normal baseline neurologic assessments; 9-fold when comparing third and first trimester exposure. Risk of MDI developmental delay increases by 8% for each week of gestational age at time of exposure.

The feasibility of establishing parent support groups for children with congenital Zika syndrome and their families: a mixed-methods study.

Background: The 2015 - 2016 Zika epidemic highlighted gaps in health and social care services for parents of children with developmental disabilities. In response, we developed the 'Juntos' intervention, a 10 week community-based early intervention support group for parents of children with congenital Zika syndrome (CZS). The intervention's components include participatory learning sessions, practical skill acquisition, peer support, and psychological support, aiming to improve caregiver's knowledge and confidence in caring for their children. This study aimed to evaluate the feasibility of implementing 'Juntos' in Colombia. Methods: Two facilitators delivered 'Juntos' to four groups of 8-10 caregivers between 2017 and 2018. One researcher observed each group. Data were collected from: observation notes from 40 sessions, focus group discussions held after each session, pre- post intervention questionnaires with 34 caregivers, and semi-structured interviews conducted with four facilitators, 12 caregivers and three stakeholders. We used the Bowen framework in data analysis. Results: The feasibility evaluation revealed that 'Juntos' was highly acceptable and in demand among the target population. The intervention was predominantly delivered with fidelity. Practicality was facilitated by providing transport costs and selecting convenient locations. Additional organisational and social media support was required for successful implementation. Community health worker training may support integration and the established groups could facilitate programme expansion. However, participants perceived lack of prioritisation as a limitation within existing health systems. Participants' knowledge and confidence to care for their child improved after programme enrolment. Conclusion: The 'Juntos' intervention demonstrated high acceptability, demand, and practicality in supporting parents of children with CZS in Colombia. However, its implementation faces challenges due to existing gaps in health system support for children with CZS.

Outcomes of Congenital Zika Virus Infection During an Outbreak in Valle del Cauca, Colombia.

BACKGROUND: Despite increasing information in the literature regarding congenital Zika infection, gaps remain in our knowledge of its clinical manifestations. METHODS: We did a prospective observational study of exposed fetuses and infants whose mothers developed symptomatic and confirmed Zika infection during pregnancy in Valle del Cauca, Colombia. We performed neurological, ophthalmologic and audiologic evaluations, and classified outcomes as possibly or uncertainly related to Zika. Frequencies of outcomes were compared according to the trimester of pregnancy when infection occurred. RESULTS: We evaluated 171 products of gestation including 17 pregnancy losses and 154 patients evaluated postnatally. Ninety (52.6%) pregnancies presented an adverse outcome, 36% possibly related with Zika and the remaining 64% of uncertain relation. Infection in the first trimester had the highest frequencies of adverse outcomes possibly related with Zika compared with the second and third trimesters (39% vs. 12.5% vs. 12%) with risk ratios of adverse outcomes possibly related to Zika in pregnancies infected in the first versus second or third trimester of 3.1 (95% CI: 2.4-4.1) and 3.3 (95% CI: 2.5-4.2), respectively. The frequencies of pregnancy loss and microcephaly were 9.4% and 4.5%, respectively. Auditory and ophthalmic abnormalities possibly related with Zika were present in 3% and 6% of the patients evaluated, respectively. CONCLUSIONS: We observed a high frequency of gestational and neonatal complications in pregnant women who acquired Zika infection, especially in early pregnancy, resulting in a broad spectrum of clinical manifestations. Preventive measures are urgently needed to reduce the clinical burden during future Zika outbreaks.

Asociación entre bajo peso al nacer y parto pretermino en gestantes con signos de enfermedad periodontal atendidas en una institución del nivel primario de salud del valle del cauca-colombia / Association between low birth weight and preterm delivery in pregnant women with signs of periodontal disease treated at a primary health institution in the valle del cauca-colombia

RESUMEN INTRODUCCIÓN: El parto pretérmino (PPT) y el Bajo Peso al Nacer (BPN) y su consecuente morbilidad y mortalidad neonatal son problemas prevalentes de salud. Se ha planteado que las bacterias que participan en el desarrollo de la enfermedad periodontal (EP) estimulan la liberación de prostaglandinas, que, a su vez, estimulan el trabajo de parto, sin embargo, esta relación no ha sido claramente demostrada. OBJETIVO: Determinar la asociación entre BPN y PPT en gestantes con signos de EP en una Institución Pública de Salud. MATERIALES Y MÉTODOS: Estudio de casos y controles con relación 1:1. Los casos fueron gestantes con Recién Nacidos (RN) pretérmino (PT) <37 semanas y BPN <2.500 gr, los controles gestantes con parto a término y RN con peso >2.500 gr. Se excluyeron gestantes sin historia clínica odontológica o cuyos RN presentaron restricción del crecimiento intrauterino. Para determinar la asociación se estimaron OR con su respectivos IC al 95%, siendo estadísticamente significativo cuando el valor de P de chi2 fue menor de 0.05. RESULTADOS: El PPT/BPN supone una posible asociación con el antecedente familiar de hipertensión o diabetes OR: 2,76 IC: (0,87 - 9,26); (p=0,051), y hubo una asociación estadísticamente significativa con bajo peso materno (IMC<18.5) en el primer control prenatal OR: 2,85 IC: (0,96 - 8,66); (p=0,033), gingivitis OR: 4,03 IC: (1,04 - 18,83); (p=0,021), retracciones gingivales OR: 8,1 IC: (0,98 - 68) (p=0,027) y sangrado gingival OR 6,8 IC: (1,98 - 26,45); (p=0,000). CONCLUSIONES: Los resultados de este estudio sugieren que la enfermedad periodontal puede estar asociada al PPT/BPN.

ABSTRACT INTRODUCTION: Preterm birth (PB) and Low Birth Weight (LBW), and their consequent neonatal morbidity and mortality, are prevalent health problems. It has been suggested that bacteria responsible for the development of periodontal disease stimulate the release of prostaglandin, which in turn, stimulates labor. However, this relationship has not been clearly demonstrated. OBJECTIVE: To determine the association between low birth weight and premature delivery in pregnant women with signs of periodontal disease in the population of pregnant women in a public health institution. MATERIALS AND METHODS: Case-control study with a 1: 1 ratio. For our subjects we included pregnant women who gave birth prematurely (PT) <37 weeks to babies with a LBW <2,500 gr and as controls, pregnant women who delivered at term with newborns weighing more than 2,500 gr. Pregnant women without a dental history were excluded as were those whose NB presented an intrauterine growth restriction. To determine the association, we used the OR with its respective 95% confidence interval, it was statistically significant when the p values of chi test was less than 0.05. RESULTS: PB / LBW indicates a possible association with the family history of hypertension or diabetes OR: 2.76 CI: (0.87 - 9.26); (p = 0.051), and there was a statistically significant association with low maternal weight (BMI <18.5) in the first prenatal control OR: 2.85 IC: (0.96 - 8.66); (p = 0.033), gingivitis OR: 4.03 IC: (1.04 - 18.83); (p = 0.021), gingival retractions OR: 8.1 IC: (0.98 - 68) (p = 0.027) and gingival bleeding OR 6.8 CI: (1.98-26.45); (p = 0.000). CONCLUSIONS: The results of this study suggest an association between signs of periodontal disease and PB / LBW.

Prevalencia y factores relacionados con la presencia de manifestaciones orales en pacientes con VIH/SIDA, Cali, Colombia / Prevalence and factors related with the presence of oral manifestations in HIV/AIDS patients who attended health institutions in Cali, Colombia

Objetivo: Determinar la prevalencia y factores relacionados con la presencia de manifestaciones orales en pacientes VIH/SIDA que asistieron a instituciones prestadoras de salud en Cali, Colombia. Materiales y métodos: Se realizó un estudio descriptivo transversal que incluyó 319 pacientes que asistían a 4 instituciones prestadoras de salud en Cali. Los criterios de inclusión fueron ser paciente VIH confirmado, mayor de 18 a±os, asistir a control médico y tener voluntad de participar. Se excluyeron mujeres embarazadas y reclusos. Resultados: La prevalencia general de manifestaciones orales fue 77.1% (IC 95%: 72.4-81.7). La mßs frecuente fue la xerostomía con 41.1% (IC 95%: 35.5-46.6), seguida por las manifestaciones de origen micótico [(35.7% (IC 95% 30.4-41)] bacteriano [34.2% (IC 95%: 28.9-39.4)] virales [16.6% (IC 95% 12.5.20.7)], úlceras orales [(7.5 (IC 95%: 4.6-10.4)] y neoplasicas [3.8 (IC 95% 1.6-5.8)]. No se presentó linfoma no Hodgkin. En el analisis multivariado, la presencia de lesiones orales se asoció con un tiempo diagnóstico de la enfermedad menor a 12 meses, carga viral detectable, presencia de prótesis dental removible y el auto-informe de boca reseca. Conclusión: La prevalencia de manifestaciones orales registrada en esta población es alta comparada con las informadas a nivel mundial. Teniendo en cuenta las asociaciones encontradas, se puede sugerir que las lesiones orales son características clínicas iniciales de la enfermedad y son predictores de progresión de VIH a SIDA y falla de tratamiento.

Aim: To determine the prevalence and factors related with the presence of oral manifestations in HIV/AIDS patients who attended health institutions in Cali-Colombia. Materials and methods: A cross-sectional descriptive study was made in 319 patients who attended four health institutions in the city of Cali. The inclusion criteria were: being HIV positive patients, being over 18 years old, attending medical checkups and accepting participation. Pregnant women and inmates were excluded. Results: The general prevalence of oral manifestations was 77.1% (CI 95%: 72.4-81.7). The most frequent oral manifestation was xerostomia with 41.1% (CI 95%: 35.5-46.6), followed by the manifestations from mycotic origin [(35.7% (CI 95% 30.4-41)] bacterial [34.2% (CI 95%: 28.9-39.4)] virals [16.6 (CI 95% 12.5-20.7)], oral ulcers [7.5 (CI 95%: 4.6-10.4)] and neoplastics [3.8 (CI95% 1.6-5.8)]. The population studied did not show non-Hodgkins lymphoma. In the multivariate analysis, the presence of oral injuries was associated with time of HIV/AIDS diagnosis during the previous 12 months, detectable viral load, and presence of removable dental prosthesis and self-report of dry mouth. Conclusions: The prevalence of oral manifestations registered in this population is high compared with those reported world-wide. Considering the association found, our results suggest that oral injuries are initial clinic characteristics of the disease and may be useful to predict treatment failure and progression from HIV infection to AIDS.

Prevalencia y factores relacionados con la presencia de manifestaciones orales en pacientes con VIH/SIDA, Cali, Colombia

Objetivo: Determinar la prevalencia y factores relacionados con la presencia de manifestaciones orales en pacientes VIH/ SIDA que asistieron a instituciones prestadoras de salud en Cali, Colombia.Materiales y métodos: Se realizó un estudio descriptivo transversal que incluyó 319 pacientes que asistían a 4 instituciones prestadoras de salud en Cali. Los criterios de inclusión fueron ser paciente VIH confirmado, mayor de 18 años, asistir a control médico y tener voluntad de participar. Se excluyeron mujeres embarazadas y reclusos.Resultados: La prevalencia general de manifestaciones orales fue 77.1 porciento (IC 95 porciento: 72.4-81.7). La más frecuente fue la xerostomía con 41.1 porciento (IC 95 porciento: 35.5-46.6), seguida por las manifestaciones de origen micótico [(35.7 porciento (IC 95 porciento 30.4-41)] bacteriano [34.2 porciento (IC 95 porciento: 28.9-39.4)] virales [16.6 porciento (IC 95 porciento 12.5.20.7)], úlceras orales [(7.5 (IC 95 porciento: 4.6-10.4)] y neoplásicas [3.8 (IC 95 porciento 1.6-5.8)]. No se presentó linfoma no Hodgkin. En el análisis multivariado, la presencia de lesiones orales se asoció con un tiempo diagnóstico de la enfermedad menor a 12 meses, carga viral detectable, presencia de prótesis dental removible y el auto-informe de boca reseca.Conclusión: La prevalencia de manifestaciones orales registrada en esta población es alta comparada con las informadas a nivel mundial. Teniendo en cuenta las asociaciones encontradas, se puede sugerir que las lesiones orales son características clínicas iniciales de la enfermedad y son predictores de progresión de VIH a SIDA y falla de tratamiento.(AU)